阿贝马西利布,帕尔博西利布和利博西利布的代谢运输和抵抗机制的差异
1Department of Pharmaceutics, Shanghai Eighth People's Hospital, Shanghai, China.
Frontiers in pharmacology
|July 21, 2023
概括
循环素依赖性激酶4/6抑制剂 (CDK4/6i) 在代谢,运输和抵抗机制上有所不同. 了解这些差异是优化癌症治疗有效性和安全性的关键.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 循环素依赖性激酶4/6抑制剂 (CDK4/6i) 在治疗乳腺癌方面至关重要.
- 了解耐药性机制对于全球癌症研究至关重要.
- CDK4/6i之间的变化会影响它们的临床效用.
研究的目的:
- 总结阿贝马西利布,帕尔博西利布和利博西利布之间的代谢和运输变化.
- 为了比较FDA批准的CDK4/6抑制剂的耐药性机制.
- 讨论这些差异如何影响抗癌药物的有效性和安全性.
主要方法:
- 在2023年3月进行的PubMed,Embase和Web of Science的文献搜索.
- 对CDK4/6抑制剂的代谢,运输和耐药性研究的综述.
- 对临床前药理学,药理动力学和临床数据的分析.
主要成果:
- CDK4/6i之间存在代谢和运输的差异,与它们的化学结构有关.
- 临床前和临床数据显示了药理学,药理动力学,安全性和有效性的差异.
- 遗传突变和药物耐受性等因素会影响耐药性,但这三种药物之间的具体差异在很大程度上是未知的.
结论:
- 尽管有共同的功能,Abemaciclib,Palbociclib和Ribociclib表现出不同的特性.
- 需要进一步的研究来阐明每个CDK4/6抑制剂的特定耐药性机制.
- 了解这些差异对于推进个性化癌症治疗至关重要.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Carrier-Mediated Transport
470
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
470
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
593
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
593
Hepatic Drug Clearance: Role of Transporters
86
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
86
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.9K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.9K
Drug Absorption Mechanism: Passive Membrane Transport
4.1K
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
4.1K


